95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-23.42%
Negative revenue growth while AEM stands at 9.67%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-18.86%
Negative gross profit growth while AEM is at 88.36%. Joel Greenblatt would examine cost competitiveness or demand decline.
-23.52%
Negative EBIT growth while AEM is at 792.05%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-23.52%
Negative operating income growth while AEM is at 792.05%. Joel Greenblatt would press for urgent turnaround measures.
463.45%
Net income growth above 1.5x AEM's 21.22%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
460.00%
EPS growth above 1.5x AEM's 17.86%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
460.00%
Diluted EPS growth above 1.5x AEM's 17.86%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-31.36%
Negative OCF growth while AEM is at 84.58%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-31.00%
Negative FCF growth while AEM is at 304.44%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
124.38%
10Y revenue/share CAGR at 50-75% of AEM's 190.23%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
-20.60%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-3.10%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
100.65%
10Y OCF/share CAGR at 75-90% of AEM's 112.03%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
-41.38%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-15.46%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
22.82%
Below 50% of AEM's 62.74%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-66.69%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-37.90%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
256.57%
10Y equity/share CAGR above 1.5x AEM's 98.20%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
44.22%
5Y equity/share CAGR above 1.5x AEM's 10.65%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
17.38%
3Y equity/share CAGR similar to AEM's 17.98%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
43.26%
AR growth well above AEM's 22.91%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
-1.10%
Negative asset growth while AEM invests at 4.07%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.73%
Under 50% of AEM's 5.38%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-10.81%
We’re deleveraging while AEM stands at 0.02%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
114.57%
We expand SG&A while AEM cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.